2021
Association of Heart and Lung Radiation Dose With COVID-Related Mortality
Talcott W, Peters G, Yu J, Park H. Association of Heart and Lung Radiation Dose With COVID-Related Mortality. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e424-e425. PMCID: PMC8536215, DOI: 10.1016/j.ijrobp.2021.07.1212.Peer-Reviewed Original ResearchLung radiation doseCOVID-19 infectionCOVID-related mortalityStudy cohortRadiation therapyOdds ratioRadiation dosePoor COVID-19 outcomesCOVID-19 positive patientsDosimetric parametersNon-metastatic patientsMultivariable logistic regressionConfidence intervalsNormal lung tissuesCOVID-19 outcomesLung radiation therapyCOVID-19MATERIAL/METHODSPrior radiation doseCardiovascular sequelaeEvaluable patientsHeart dosesHeart V5Lung V5Association of heart
2015
Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy
Harder EM, Park HS, Nath SK, Mancini BR, Decker RH. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy. Practical Radiation Oncology 2015, 5: e643-e649. PMID: 26412341, DOI: 10.1016/j.prro.2015.07.003.Peer-Reviewed Original ResearchConceptsStereotactic body radiation therapyACE inhibitor useNonsteroidal anti-inflammatory drugsAngiotensin receptor blockersRadiation pneumonitisSymptomatic radiation pneumonitisInhibitor useBody radiation therapyAnti-inflammatory drugsRadiation therapyReceptor blockersACE inhibitorsAngiotensin-converting enzyme inhibitor useACE inhibitor usersCommon Terminology CriteriaEnzyme inhibitor usePrimary lung cancerNormal lung tissuesAvailable medical recordsCox proportional hazardsPulmonary doseTerminology CriteriaInhibitor usersAdverse eventsOverall survival